As part of a Medicinal Chemistry program aimed at developing an orally bioavailable selective estrogen receptor degrader, a number of tritium, carbon-14, and stable isotope labelled (E)-3-[4-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl]prop-2-enoic acids were required. This paper discusses 5 synthetic approaches to this compound class.
作为旨在开发口服
生物可利用的选择性
雌激素受体降解剂的药物
化学计划的一部分,许多氚、碳 14 和稳定同位素标记 (E)-3-[4-(2,3,4,9-四氢需要-1H-
吡啶并[3,4-b]
吲哚-1-基)苯基]丙-2-烯酸。本文讨论了该化合物类别的 5 种合成方法。